全文获取类型
收费全文 | 218783篇 |
免费 | 18823篇 |
国内免费 | 7062篇 |
专业分类
耳鼻咽喉 | 1654篇 |
儿科学 | 3990篇 |
妇产科学 | 1842篇 |
基础医学 | 26499篇 |
口腔科学 | 3478篇 |
临床医学 | 20664篇 |
内科学 | 28461篇 |
皮肤病学 | 3207篇 |
神经病学 | 10144篇 |
特种医学 | 4769篇 |
外国民族医学 | 28篇 |
外科学 | 16634篇 |
综合类 | 30715篇 |
现状与发展 | 16篇 |
一般理论 | 28篇 |
预防医学 | 14588篇 |
眼科学 | 5004篇 |
药学 | 44777篇 |
42篇 | |
中国医学 | 10736篇 |
肿瘤学 | 17392篇 |
出版年
2024年 | 488篇 |
2023年 | 2795篇 |
2022年 | 5512篇 |
2021年 | 7666篇 |
2020年 | 6935篇 |
2019年 | 7231篇 |
2018年 | 7317篇 |
2017年 | 7386篇 |
2016年 | 7203篇 |
2015年 | 7241篇 |
2014年 | 11601篇 |
2013年 | 15323篇 |
2012年 | 11146篇 |
2011年 | 12343篇 |
2010年 | 10525篇 |
2009年 | 10080篇 |
2008年 | 10072篇 |
2007年 | 11054篇 |
2006年 | 9979篇 |
2005年 | 9687篇 |
2004年 | 8505篇 |
2003年 | 7712篇 |
2002年 | 6684篇 |
2001年 | 6845篇 |
2000年 | 5989篇 |
1999年 | 5086篇 |
1998年 | 3997篇 |
1997年 | 3561篇 |
1996年 | 3167篇 |
1995年 | 2761篇 |
1994年 | 2323篇 |
1993年 | 2031篇 |
1992年 | 1825篇 |
1991年 | 1567篇 |
1990年 | 1312篇 |
1989年 | 1224篇 |
1988年 | 1151篇 |
1987年 | 934篇 |
1986年 | 700篇 |
1985年 | 818篇 |
1984年 | 809篇 |
1983年 | 542篇 |
1982年 | 609篇 |
1981年 | 516篇 |
1980年 | 430篇 |
1979年 | 366篇 |
1978年 | 316篇 |
1977年 | 259篇 |
1976年 | 287篇 |
1975年 | 200篇 |
排序方式: 共有10000条查询结果,搜索用时 515 毫秒
31.
32.
33.
34.
Cristiano Colalto 《Drug development research》2020,81(8):950-968
COVID-19 is a novel coronavirus disease with a higher incidence of bilateral pneumonia and pleural effusion. The high pulmonary tropism and contagiousness of the virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have stimulated new approaches to combat its widespread diffusion. In developing new pharmacological strategies, the chemical characteristic of volatility can add therapeutic value to the hypothetical drug candidate. Volatile molecules are characterized by a high vapor pressure and are consequently easily exhaled by the lungs after ingestion. This feature could be exploited from a pharmacological point of view, reaching the site of action in an uncommon way but allowing for drug delivery. In this way, a hypothetical molecule for COVID-19 should have a balance between its lung exhalation characteristics and both antiviral and anti-inflammatory pharmacological action. Here, the feasibility, advantages, and disadvantages of a therapy based on oral administration of possible volatile drugs for COVID-19 will be discussed. Both aerosolized antiviral therapy and oral intake of volatile molecules are briefly reviewed, and an evaluation of 1,8-cineole is provided in view of a possible clinical use and also for asymptomatic COVID-19. 相似文献
35.
《Vaccine》2020,38(3):570-577
IntroductionPediatric pneumococcal pneumonia complicated by parapneumonic pleural effusion/empyema (PPE/PE) remains a major concern despite general immunization with pneumococcal conjugate vaccines (PCVs).MethodsIn a nationwide pediatric hospital surveillance study in Germany we identified 584 children <18 years of age with bacteriologically confirmed PPE/PE from October 2010 to June 2018. Streptococcus pneumoniae was identified by culture and/or PCR of blood samples and/or pleural fluid and serotyped.ResultsS. pneumoniae was identified in 256 of 584 (43.8%) children by culture (n = 122) and/or PCR (n = 207). The following pneumococcal serotypes were detected in 114 children: serotype 3 (42.1%), 1 (25.4%), 7F (12.3%), 19A (7.9%), other PCV13 serotypes (4.4%) and non-PCV13 serotypes (7.9%). Between October 2010 and June 2014 serotype 1 (38.1%) and serotype 3 (25.4%) were most prevalent, whereas between July 2014 and June 2018 serotype 3 (62.7%) and non-PCV13 serotypes (15.7%) were dominant. Compared to children with other pneumococcal serotypes, children with serotype 3 associated PPE/PE were younger (median 3.2 years [IQR 2.1–4.3 years] vs. median 5.6 years [IQR 3.8–8.2 years]; p < 0.001) and more frequently admitted to intensive care (43 [89.6%] vs. 48 [73.8%]; p = 0.04). Seventy-six of 114 (66.7%) children with pneumococcal PPE/PE had been vaccinated with pneumococcal vaccines. Thirty-nine of 76 (51.3%) had received a vaccine covering the serotype detected. Thirty of these 39 breakthrough cases were age-appropriately vaccinated with PCV13 and considered vaccine failures, including 26 children with serotype 3, three children with serotype 19A and one child with serotype 1.ConclusionFollowing the introduction of PCV13 in general childhood vaccination we observed a strong emergence of serotype 3 associated PPE/PE in the German pediatric population, including a considerable number of younger children with serotype 3 vaccine breakthrough cases and failures. Future PCVs should not only cover newly emerging serotypes, but also include a more effective component against serotype 3. 相似文献
36.
37.
Interstitial cystitis/bladder pain syndrome (IC/BPS) and vulvodynia are chronic pain syndromes that appear to be intertwined from the perspectives of embryology, pathology and epidemiology. These associations may account for similar responses to various therapies. 相似文献
38.
39.
40.